CRP and Obesity: When looking at DAS28-CRP low disease activity as a less stringent definition of response to treatment, we have seen that participants with baseline obesity also had a lower likelihood to achieve DAS28-CRP low disease activity compared with participants with BMI <30 kg/m2 (online supplemental figure 2).